CHANGES IN BONE MINERAL METABOLISM PARAMETERS, INCLUDING FGF23, AFTER DISCONTINUING CINACALCET AT KIDNEY TRANSPLANTATION.

  1. Inicio
  2. »
  3. Sin categoría
  4. »
  5. CHANGES IN BONE MINERAL METABOLISM PARAMETERS, INCLUDING FGF23, AFTER DISCONTINUING...

We conclude that patients receiving cinacalcet on dialysis presented similar serum phosphate levels but higher PTH and serum calcium levels during the initial six months after kidney transplantation than cinacalcet non-treated patients. The group previously treated with cinacalcet before transplantation showed higher FGF23 levels without significant differences, so further studies should investigate its relevance in the management of these patients.

Patrocinadores de la web
Lilly
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Gebro
Faes Farma
Meiji Pharma